From Research
03.12.24
ERC: two researchers from San Raffaele-Telethon institute for gene therapy in Milan each receive 2 million euros for their prestigious funding together with IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele
Daniela Cesana and Alessio Cantore presented two projects, respectively to investigate the impact, safety and efficacy of gene therapy through the 'signatures' of circulating DNA and to investigate the biology of liver cells in order to exploit them in the field of gene therapy.
28.11.24
Gene therapy: target liver
At the San Raffaele-Telethon Institute in Milan, an innovative liver-directed gene transfer platform applicable to various metabolic diseases has been developed thanks to the efforts of the research group led by Alessio Cantore, together with the biotech company Genespire.
18.11.24
Mucopolysaccharidosis 6 and gene therapy: present and future
A study just published by TIGEM researchers shows how the efficacy of this experimental therapy is maintained over time, at the highest doses. Study coordinator Brunetti-Pierri reports on possible future developments
16.09.24
Naples, world's first genere therapy for a rare retinal disease
The surgery, performed at AOU Vanvitelli, was made possible by an innovative gene therapy platform developed by Pozzuoli's TIGEM that allows for large gene transfer.
20.02.23
San Raffaele-Telethon Institute receives European funds to study how blood is formed
Andrea Ditadi awarded an ERC Consolidator Grant worth 2 million euro
17.12.22
New frontiers for gene therapy
At the San Raffaele-Telethon Institute in Milan researchers are working to apply gene therapy, an approach that has already given important results, to even more diseases optimizing development times and costs.
16.05.22
Fondazione Cariplo and Fondazione Telethon: 24 projects funded with more than 5 million euros for basic research in the field of rare diseases
Winners of the 2021 Call for Basic Research have been selected from all over Italy to study the still obscure portions of our genetic heritage.
29.04.22
Generating blood in vitro: a new piece of the puzzle
An important contribution to the elucidation of the mechanisms through which blood stem cells arise during embryonic life from a study conducted by the San Raffaele Telethon Institute for Gene Therapy.
05.04.22
Gene therapy targeted to the brain: a complex but not impossible challenge
Angela Gritti from the San Raffaele Telethon Institute of Milan talks about the efforts of applying gene therapy to one of the most difficult body organs to access.
